Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2026 (TTM): NZ$0.08400

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is NZ$0.08919. In 2025 the company made an earnings per share (EPS) of NZ$0.06114 a decrease over its 2024 EPS that were of NZ$0.08059.

EPS history for Shanghai RAAS Blood Products from 2005 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	NZ$0.08400	37.39%
2025	NZ$0.06114	-24.13%
2024	NZ$0.08059	18.38%
2023	NZ$0.06808	-5.91%
2022	NZ$0.07236	36.15%
2021	NZ$0.05314	-7.39%
2020	NZ$0.05739	87.44%
2019	NZ$0.03062	-138.11%
2018	NZ-$0.08034	-272.5%
2017	NZ$0.04657	-45.02%
2016	NZ$0.08470	5.85%
2015	NZ$0.08002	127.47%
2014	NZ$0.03518	48.29%
2013	NZ$0.02372	29.9%
2012	NZ$0.01826	13.1%
2011	NZ$0.01615	14.18%
2010	NZ$0.01414	40.49%
2009	NZ$0.01007	13.05%
2008	NZ$0.008905	18.08%
2007	NZ$0.007542	-37.8%
2006	NZ$0.01213	2.48%
2005	NZ$0.01183

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)